Bristol-Myers Squibb (NYSE: BMY) is an American pharmaceutical company which manufactures prescription pharmaceuticals and biologics in several therapeutic areas with particular success in cardiovascular treatments.
Since 2008, BMY established an impulsive rally taking the stock to new all time highs after it managed to break above 1999 peak which opened a multi-year bullish sequence. The cycle lasted for 8 year before it finally ended in 2016 and started a 3 years correction.
Based on the , after five waves takes place, a three waves pullback follows. The stock turned lower and did a lower until 07.23.2019, as we show in the following chart.
BMY Weekly Chart
Up from there, BMY started to rally within a new impulsive structure suggesting the end of the correction and the resuming of the main trend which is bullish. Consequently, the stock is expected to remain supported during short term pullbacks against $42.48 and will be aiming for a break above $77.12 which will open a new weekly bullish sequence aiming for a target at equal legs area $103 – $118.
Get more insights about Stocks and ETFs by . You’ll learn how to trade the market in the right side using the 3, 7 or 11 swings sequence. You will get access to our 78 instruments updated in 4 different time frames, Live Trading & Analysis Session done by our Expert Analysts every day, 24-hour chat room support and much more.
